Myosin-II thick filament formation in
A portion of the myosin tail coupled to a green fluorescent protein "head" proves a valuable model for understanding myosin self-assembly
Myosin-II (hereafter referred to as myosin) is a hexameric protein composed of two heavy chains, two regulatory light chains, and two essential light chains (
(A) The myosin head (1–818) and light chains are shown at the N terminus. In the coiled-coil tail, Ala 1 is red (1,348–1,530), the AD is blue (1,531–1,824), Ala 2 is purple (1,825–1,966), the C-terminal domain is green (1,967–2,116), and the remainder is black (819–1,347). Phospho-threonines (at positions 1,823, 1,833, and 2,029) are indicated by the letter T.
(B and C) Plots of the average charge of each tail domain color coded as in (A). The y-axis is average charge; the x-axis is tail position. Aspartic acid and glutamic acid are assigned –1, lysine and arginine are assigned +1, and all other a.a. are assigned 0. The average charge in (B) was determined with a window size of 14 a.a., and the average charge in (C) was determined with a window size of 28 a.a.. Arrows highlight the 28 a.a. charge repeat in (B) and the 196 a.a. charge repeat in (C).
(D) “Headless” AD-Cterm (3xThr) (1,531–2,116).
A bipolar thick filament (BTF) is a highly organized structure composed of individual myosin molecules. In vitro, myosin from the cellular slime mold
In vivo, BTFs are important in a variety of cellular processes, including cell motility, chemotaxis, and development. In cytokinesis, BTFs provide the mechanical force to constrict an actin ring positioned at the midzone of the dividing cell (
Phosphorylation of only three threonines in the 2,116-amino acid (a.a.) heavy chain of myosin is sufficient to inhibit BTF formation (
Myosin tails have a striking pattern of charged a.a., with an average positive charge over 14 a.a. followed by an average negative charge over 14 a.a. to form a 28-a.a. charge repeat throughout the tail (
The C-terminal 68 kDa of the tail contains the 34-kDa assembly domain (AD; a.a. 1,531–1,824;
Replacement of the catalytic domain and essential light chain binding domain of full-length
Several models have been proposed for the mechanism of myosin regulation. In this discussion, the hexameric myosin molecule will be referred to as a monomer (
An alternative monomer-sequestering mechanism might be destabilization of the coiled-coil. Threonine 1,823 is located at the C terminus of the AD, and is predicted to be in the D position of the heptad repeat. The D position is in the core of the coiled-coil where the two strands interact closely. It is possible that phosphorylation of threonine 1,823 would cause a local disruption of the coiled-coil and perturb self-assembly by introducing negative charge into the hydrophobic core (
Another model postulates that regulation occurs at the level of assembly intermediates. The assembly pathway of full-length
When two myosin monomers are offset by 14 nm, both the 28-a.a. and 196-a.a. charge repeats are aligned to maximize charge complementation between the two tails (
Determining the mechanism of regulated assembly will help elucidate the largely uncharacterized mechanism of myosin recruitment to the cleavage furrow. Reports that 3xAsp myosin does not localize, while 3xThr (i.e., wild-type) and 3xAla can localize, have demonstrated the necessity of BTF assembly for proper localization of myosin (
Characterization of
We wished to test whether both the Ala 1 and the Ala 2 domains of myosin are necessary to regulate BTF assembly (
Thick filaments and paracrystals efficiently sediment upon centrifugation, whereas unassembled molecules remain soluble. Wild-type full-length myosin efficiently assembles in buffers of intermediate ionic strength (25–100 mM NaCl), while phosphorylated full-length myosin is unassembled (
(A) Analysis of assembly by sedimentation. Fraction of soluble protein as a function of NaCl concentration is plotted for the constructs depicted adjacent to the graph. The solubility of “headless” AD-Cterm (3xThr) and AD-Cterm (3xAsp) are compared to the solubility of unphosphorylated and phosphorylated full-length myosin having the globular motor domain (full-length myosin data from
(B) Sedimentation equilibrium analysis of 52 μM “headless” AD-Cterm (3xThr) and AD-Cterm (3xAsp) in buffer containing 500 mM NaCl. The top graphs show the concentration distribution, fit, and residuals for AD-Cterm (3xThr), while the bottom graphs show the same data for AD-Cterm (3xAsp). The molecular weight obtained from the fit was 130 kDa for AD-Cterm (3xThr) and 120 kDa for AD-Cterm (3xAsp).
(C) Thermal melts of “headless” AD-Cterm (3xThr) and AD-Cterm (3xAsp) in buffer containing 500 mM NaCl are shown as fraction of protein denatured as a function of temperature. The open circles are data for 50 μM “headless” AD-Cterm (3xThr), and the open squares are data for 50 μM “headless” AD-Cterm (3xAsp).
We next tested whether AD-Cterm (3xThr) and AD-Cterm (3xAsp) tail fragments form coiled-coils, similar to full-length myosin. The oligomerization state of the tail fragments was determined by sedimentation equilibrium analysis, and the secondary structure was assessed by circular dichroism (CD). Neither tail fragment is expected to assemble in the buffers used for these studies, as they contain 500 mM NaCl. Sedimentation runs were carried out as a function of protein concentration, and equilibrium traces were obtained after 20 h of centrifugation. The profiles were fit to an equation describing the sedimentation behavior of a single, non-associating, ideal species (
The sedimentation equilibrium analysis demonstrates that a direct comparison of coiled-coil stability can be made by thermal denaturation at 500 mM NaCl because neither tail fragment self-assembles to form larger species in this condition. Thermal melts are reversible and at equilibrium and far-UV CD spectra show both tail fragments are α-helical at the starting temperature of the melt (4 °C) and are random coil at the ending temperature (60 °C) (unpublished data). The melting temperature for the AD-Cterm (3xThr) and AD-Cterm (3xAsp) tail fragments at both protein concentrations are identical (29 °C at 50 μM and 28 °C at 2.5 μM;
The AD-Cterm data show that tail fragment solubility accurately predicts the bulk solubility properties of full-length myosin. However, they do not form true BTFs. When AD-Cterm (3xThr) is assembled in buffer containing 50 mM NaCl with 10 mM MgCl2 and imaged using negative-stain (EM), it forms paracrystals with a 14-nm (98-a.a.) periodicity, corresponding to the periodicity of charge in the AD-through-C-terminal region of the myosin tail (
(A and B) The scale bars are 100 nm, and all panels are on the same scale. (A) The “headless” AD-Cterm (3xThr) tail fragment assembled for 2 h. (B) Three images of GFP-AD-Cterm (3xThr) assembled for 2–5 min.
(C) Analysis of GFP AD-Cterm (3xThr) (open circles) and GFP-AD-Cterm (3xAsp) (open squares) assembly by sedimentation.
To test whether the presence of a globular domain might induce AD-Cterm to form regulated, bipolar structures analogous to the thick filaments formed by full-length
We assembled purified GFP-AD-Cterm (3xThr) in buffer containing 50 mM NaCl with 10 mM MgCl2 and imaged them using EM. Bipolar structures first formed on a time scale of 2–5 min (
We compared the dimensions of GFP-AD-Cterm (3xThr) and full-length myosin BTFs (
Notably, the solubility properties of GFP-AD-Cterm (3xThr) and GFP-AD-Cterm (3xAsp) (
To test the ability of GFP-tail fragments to localize to the cleavage furrow of
We used live-cell fluorescence microscopy to study the localization of the GFP-RLC-tail fragments in
The localization of several GFP-RLC-myosin tail fragments during and just after cytokinesis in live
To examine the specificity of myosin BTF localization, we examined whether any object of comparable length to a BTF is enriched at the cleavage furrow during cytokinesis (
(A) Time course of a representative GMO8B
(B) Plot of the location of each bead in each of six dividing cells in the six frames imaged during cytokinesis. The axes were defined in each frame to bisect the center of the cell both horizontally and vertically such that the center of the furrow is the origin of the axes. The position of each bead was then plotted relative to these axes. Different beads are represented by different colors. For three of the beads, the trajectory of the bead is shown with arrows. The average location of a cell is outlined on the plot in transparent green.
The data detailed in
For tail fragments that include more than one domain, the name is determined by the first and last domain in the tail fragment. Phosphorylation sites are indicated in parentheses. 1xThr indicates that the fragment contains the threonine at a.a. 1,823; 2xThr indicates that the fragment contains the threonines at a.a. 1,823 and 1,833; and 3xThr indicates that the fragment contains the threonines at a.a. 1,823, 1,833, and 2,029. The same scheme is used to describe aspartic acid-containing constructs in the paper, except threonine is substituted with aspartic acid.
Given the large contribution that a.a. 1,823, the penultimate a.a. in the AD, makes to the 3xAsp phenotype (
The solubility of the various constructs used for the truncation analysis is compared.
(A) Comparison of “headless” AD (1xThr) and “headless” AD (1xAsp).
(B) Comparison of “headless” AD (1xThr), GFP-AD (1xThr), and GFP-AD-Cterm (3xThr). The GFP is located at the N-terminus in both GFP-containing constructs.
(C) Comparison of “headless” extended AD (2xThr) and “headless” extended AD (2xAsp).
(D) Comparison of “headless” AD-Ala2 (2xThr) and “headless” AD-Ala2 (2xAsp).
(E) Comparison of “headless” AD-Cterm (3xThr), “headless” Ala1-Ala2 (2xThr), and “headless” Ala1-Cterm (3xThr).
We attached a GFP “head” to the AD (1xThr) and, interestingly, this GFP-AD (1xThr) tail fragment had bulk sedimentation properties very similar to those of headless AD (1xThr), suggesting that the presence of a globular domain does not affect in vitro solubility, similar to AD-Cterm and GFP-AD-Cterm tail fragments (
To determine whether the entire 34-kDa portion of the tail C-terminal to the AD is required for regulated assembly, we generated a series of tail fragments that all start at the AD and are truncated at different positions within the C-terminal 34 kDa of the tail (see
To test whether adding on a larger portion of the tail results in a greater degree of regulated assembly, we constructed tail fragments that start at the AD and end at a.a. 1,966, the end of Ala 2 (AD-Ala 2). As with other tail fragments, the aspartic acid variant of this construct is more soluble than its wild-type counterpart (
When the entire C-terminal domain is included in the AD-Cterm tail fragment, the inhibitory effect of Ala 2 is overcome. To test whether this stabilizing effect is specific to the C-terminal domain, we determined if Ala 1 could also stabilize assembly. A tail fragment was constructed that starts at Ala 1 and ends at Ala 2 (Ala1-Ala2 [2xThr]). The salt-dependent assembly of Ala1-Ala2 (2xThr) is more efficient than that of AD-Ala2 (2xThr) (
The 196-a.a. repeat is remarkably symmetric in the entire AD-Cterm region (
(A) The AD-Cterm charge distribution (top) is aligned with the reverse charge distribution (bottom), showing the overall symmetry of the 196-a.a. charge repeat in this region of the tail.
(B) Analysis of assembly by EM. The AD-Cterm (3xThr) tail fragment has GFP on the C-terminus (AD-Cterm-GFP [3xThr]). The scale bar indicates a distance of 100 nm. Shown are three images of AD-Cterm GFP (3xThr), assembled 2–5 min.
(C) Analysis of assembly by sedimentation. The solubility of AD-Cterm-GFP (3xThr) and AD-Cterm-GFP (3xAsp) tail fragments constructs are compared to GFP-AD-Cterm (3xThr) and “headless” AD-Cterm (3xThr) tail fragments.
To test whether AD-Cterm-GFP (3xThr) can form BTFs, we performed EM (
We next tested whether AD-Cterm-GFP assembly is regulated. AD-Cterm-GFP (3xAsp) is soluble at all NaCl concentrations, whereas AD-Cterm-GFP (3xThr) sediments efficiently between 25 mM and 150 mM NaCl (
The assembly properties of both AD-Cterm (3xThr) and AD-Cterm (3xAsp) closely parallel those of full-length unphosphorylated and phosphorylated myosin described by
The fact that GFP-AD-Cterm (3xThr) forms BTFs whereas AD-Cterm (3xThr) does not, demonstrates that the mere presence of a globular head differentiates BTFs from paracrystals, and that neither the myosin head nor the S2 region of the myosin coiled-coil is critical for BTF formation (
GFP-RLC-AD-Cterm tail fragments demonstrate regulated recruitment to the cleavage furrow during cytokinesis. While the localization of GFP-RLC-AD-Cterm (3xThr) is less robust than full-length myosin, constitutively assembled GFP-RLC-AD-Cterm (3xAla) always localizes to the cleavage furrow in cytokinesis (see
The difference in localization efficiency between full-length myosin and GFP-RLC-AD-Cterm (3xThr) might be due to differences in degree of assembly. The critical concentration of full-length myosin is estimated to be less than 20 nM (
Interestingly, beads that are approximately the same length as the BTFs formed from full-length myosin do not localize to the cleavage furrow. Together with the previous in vivo localization data, this result argues that the majority of the information necessary for localization of BTFs to the cleavage furrow is in the AD-Cterm portion of the myosin tail, and that localization to the cleavage furrow is an active process, possibly involving another cellular factor that recruits myosin. It may be that this factor recognizes the charge repeats that distinguish assembled myosin BTFs from unassembled myosin. Consistent with this model is the localization of chimeric myosin molecules to the cleavage furrow in
Our finding that the in vitro self-assembly of AD-Cterm (3xThr) and AD-Cterm (3xAsp) are very similar to full-length, wild-type myosin and full-length, phosphorylated myosin, respectively, show that Ala 1 is not required for regulated assembly. This result has been confirmed in vivo by deleting Ala 1 from both full-length wild-type and 3xAsp myosin (W. Liang and JAS, unpublished data).
The CD and analytical ultracentrifugation data show that AD-Cterm (3xAsp) has not simply failed to fold into a two-stranded α-helical coiled-coil. These data are consistent with rotary shadowed electron micrographs of full-length 3xAsp and phosphorylated myosin. Gross destabilization of the coiled-coil would result in a single-headed myosin, and none have been observed (
Small numbers of assembled AD-Cterm (3xAsp) paracrystals were seen in electron micrographs of samples (unpublished data). These paracrystals, although quite rare, possess a 14-nm periodicity similar to the wild-type tail fragment. Consistent with this observation, approximately 10% of 3xAsp myosin sediments at 50 mM NaCl, demonstrating that regulation of assembly is not an all-or-none process. Together with the CD data, this result indicates that AD-Cterm (3xAsp) is structurally and functionally intact. Rather than being conformationally disrupted, the 3xAsp tail fragment fails to assemble because the critical concentration for assembly is higher than that of the wild-type tail fragment.
The fact that AD-Cterm-GFP forms BTF-like structures with heads on the outside and tails in the center demonstrates the role of the 196-a.a. charge repeat in assembly. This charge repeat is symmetric in the AD-Cterm region of the tail (see
Interestingly, AD-Cterm-GFP (3xThr) structures are shorter than GFP-AD-Cterm (3xThr) filaments, and the bare zones are smaller as well. This may be because C-terminal sequence elements in the myosin tail may be required for proper formation of the bare zone and thereby determine the exact morphology of the BTF.
The truncation analysis provides evidence of a delicate balance between forces that drive assembly and disassembly of myosin tails. This is most strikingly demonstrated by the observation that Ala 2 was actually found to inhibit the assembly of AD, while Ala 1 and the C-terminal domain help to drive assembly. We propose that that this delicate balance is related to the 196-a.a. charge repeat in the tail. The attachment of Ala 2 (purple,
Because the charge repeats likely play a role in each step in the assembly pathway, a small effect, such as the introduction of negative charge at key points in the molecule, could have a large effect on overall self-assembly. The threonine phosphorylation sites are positioned near the positive clusters of charge at the end of AD and in the C-terminal domain, suggesting that regulation by phosphorylation might have its largest effect on this charge pattern.
The polymerase chain reaction (PCR) was used to amplify the regions of a
Tail fragments contain an N-terminal methionine followed by these a.a. from
The constructs described above are the source of tail fragment DNA for all GFP constructions. To create N-terminal fusions, 5′ and 3′ ends of GFP-UV (
To create C-terminal GFP fusions, the 5′ and 3′ ends of GFP-UV in the GFP-UV-pET28a vector were modified by PCR. The 5′ primer eliminated the N-terminal 6xhistidine tag and introduced a SacI site. The 3′ primer eliminated an internal SacI site and introduced a 6xhistidine tag, followed by a stop codon, followed by a NotI site. Quikchange mutagenesis (Stratagene) was used to eliminate the stop codon immediately before the SacI site in the AD-Cterm tail fragments contained in pET21a. The modified GFP-UV was subcloned into this vector using SacI and NotI. All DNA sequences were verified.
To make N-terminal GFP-tail constructs for expression in
All tail fragment constructs were transformed into the BL21-CodonPlus (DE3)-RIL strain (Stratagene). LB media contained 34 μg/ml chloramphenicol and either 100 μg/ml kanamycin for pET28a or 100 μg/ml carbenicillin for pET21a. Cells were grown at 37 °C to an absorbance at 600 nm of approximately 0.6. Protein expression was induced by adding 1 mM IPTG and incubating for 1 h. Cells were harvested by centrifugation at 6,370 × g for 15 min.
Harvested cells were resuspended in 10 mM Tris (pH 7.4), 1 mM EDTA, 1 mM DTT, 500 mM NaCl, 30% sucrose, and protease inhibitor (PI) cocktail (final concentration of 0.7 μg/ml leupeptin, 0.7 μg/ml pepstatin A, 2 μg/ml aprotinin, and 1 mM PMSF). For a single protein prep, the pellet from 10 l of culture was resuspended in buffer for a final volume of 40 ml. Cells were added dropwise into liquid nitrogen and stored at –80 °C.
Cells were thawed and 5 μg/ml RNase A (#78020Y; USB, Cleveland, Ohio, United States), 50 μg/ml RNase-free DNase I (#776 785; Roche, Basel, Switzerland), and 10 mM MgCl2 were added. The cells were lysed with two passes through a French Press (American Instrument Company, Silver Spring, Maryland, United States) at 10,000 pounds per square inch. After the first pass, a new batch of the PI cocktail was added. The lysate was centrifuged at 100,000 × g for 30 min at 4 °C. The supernatant was boiled for 10 min, and then a new batch of the PI cocktail and 1 mM DTT was added. The boiled supernatant was centrifuged at 100,000 × g for 30 min at 4 °C and then dialyzed against DEAE Low-Salt Buffer (DEAE-LSB; 10 mM Tris [pH 8.0], 1 mM EDTA, 1 mM DTT, and PI cocktail). The protein was injected onto a column consisting of eight tandem HiTrap DEAE Sepharose Fast Flow columns (Amersham Biosciences, Little Chalfont, United Kingdom). The column was washed with 5 volumes of DEAE-LSB and protein was eluted on a linear gradient from 0 to 500 mM NaCl over 10 volumes. Fractions containing protein (typically eluting at 230 mM NaCl) were identified by SDS-PAGE. Protein was precipitated by addition of 85% (NH4)2SO4, stirred at 4 °C for 30 min, and centrifuged at 100,000 × g for 30 min at 4 °C. The pellet was resuspended in a minimal volume of gel filtration buffer (10 mM Tris [pH 8.0], 1 mM EDTA, 1 mM DTT, and 500 mM NaCl) and loaded on a HiLoad 26/60 Superdex 200 column (Amersham Biosciences). Fractions were analyzed by SDS-PAGE, and those containing pure tail fragments were pooled and dialyzed against Mono-Q Low Salt Buffer (Mono-Q LSB; 10 mM Tris [pH 8], 1 mM EDTA). Protein was injected onto a Mono Q HR 5/5 column (Amersham Biosciences) and a gradient from 0 to 1 M NaCl was run. Tail fragments typically eluted at 450 mM NaCl.
Protein concentration was determined by measuring the absorbance at 280 nm in 6M guanidine hydrochloride. The extinction coefficient was calculated using the sequence of one strand of the coiled-coil as described in
After harvesting, cells were resuspended in 50 mM sodium phosphate (pH 8.0) with 250 mM NaCl and containing PI cocktail. For a single protein prep, the pellet from 30 l of culture was resuspended in buffer for a final volume of 120 ml.
Lysis and the first centrifugation step were identical to the myosin tail fragment protocol described above except that 5 mM MgCl2 was added along with the DNase I and RNase A. The supernatant was batch-bound to Ni-NTA resin (Qiagen, Valencia, California, United States) at 4 °C for 1 h. The resin was washed with 40 ml of 50 mM sodium phosphate (pH 8.0) with 250 mM NaCl (starting buffer) followed by 20 ml of starting buffer containing 12.5 mM imidazole. Protein was eluted from the column using approximately 5 ml of starting buffer with 500 mM imidazole. Fractions containing protein were loaded onto a Hi-Load 26/60 Superdex 200 prep grade gel filtration column (Amersham). Both GFP-AD-Cterm and AD-Cterm-GFP tail fragments elute between 120 ml and 150 ml. GFP-AD elutes between 152 ml and 174 ml. Protein was dialyzed against Mono-Q LSB overnight and then injected onto the Mono-Q HR 5/5 column (Amersham Biosciences) as described above. Protein elutes at about 450 mM NaCl. Protein was used immediately after purification for microscopy and sedimentation assays.
Purified GFP-tail fragments were diluted to a final protein concentration of approximately 1 μM, a final MgCl2 concentration of 10 mM, and a final NaCl concentration of 50 mM. This solution was deposited onto glow-discharged 300-mesh carbon stabilized copper grids coated with formvar (#01753-F; Ted Pella, Redding, California, United States). AD-Cterm and AD proteins were assembled for 2 h, while GFP-containing proteins were assembled for 2 min. A 1% uranyl acetate solution was applied before imaging on a JEOL 1230 transmission electron microscope (JEOL USA, Peabody, Massachusetts, United States).
Purified protein was dialyzed overnight against 10 mM imidazole (pH = 7.5), 0.1 mM EDTA, and 1 mM DTT. 10 μM protein was added to an equal volume of 10 mM imidazole, 0.1 mM EDTA, 1 mM DTT, 2× mM NaCl. The final concentration of NaCl was × mM NaCl, where × = 0, 25, 50, 75, 100, 150, and 250 mM. Samples were incubated on ice for at least 30 min and then centrifuged at 132,000 × g for 15 min at 4 °C. Three replicates of each sample were made to ensure reproducibility. Samples of the supernatant and pellet were run on SDS-PAGE gels. The intensity of bands was quantified with an AlphaImager 2000 Documentation and Analysis System (Alpha Innotech Corporation, San Leandro, California, United States).
An Aviv Circular Dichroism Spectrometer model 62A DS was used (Aviv Corporation, Acton, Massachusetts, United States). The protein was in 10 mM Tris (pH 7.4), 500 mM NaCl, 1 mM EDTA, 1 mM DTT. Wavelength scans were taken from 260 nm to 200 nm. Data were collected every 1 nm with a 1-nm bandwidth and averaging time of 10 s. The spectra presented are buffer subtracted. Thermal melts were taken from 4 °C to 60 °C. θ222 was monitored with a 1 nm bandwidth. The temperature was increased in 1 °C increments, and the sample was equilibrated for 2 min at the new temperature before data collection. An averaging time of 30 s was used. The pmt dc voltage used was 1.0 V for 2.5 μM protein and 0.55 V for 50 μM protein. Kaleidagraph (Synergy Software, Essex Junction, Vermont, United States) was used for all data analysis. Plots of fraction denatured versus temperature were constructed as described in
AD-Cterm (3xThr) was assembled by diluting the NaCl concentration to 50 mM. Assembled protein was recovered by centrifugation at 100,000 × g for 15 min. Pellets were resuspended in 10 mM Tris (pH 7.4), 0.1 mM EDTA, 500 mM NaCl (High-Salt Buffer) and centrifuged at 100,000 × g for 15 min to remove aggregates. The AD-Cterm (3xAsp) tail fragment was centrifuged at 100,000 × g for 15 min to remove aggregates. Both tail fragments were exchanged several times into High-Salt Buffer using an Amicon Ultra-15 30,000 Dalton cut-off ultra-filtration device (Millipore, Billerica, Massachusetts, United States). The High-Salt Buffer was the blank in all analytical ultracentrifugation experiments. After buffer exchange, the protein was centrifuged at 14,000 rpm for 10 min in a microcentrifuge to remove aggregates. The protein was snap-frozen in liquid nitrogen and shipped in dry ice to the Macromolecular Interactions Facility at UNC-Chapel Hill. The protein used for all analytical ultracentrifugation experiments was centrifuged at room temperature for 15 min at 16,000 × g to remove aggregates.
All sedimentation equilibrium experiments were performed at the UNC Chapel Hill Macromolecular Interactions Facility as described in
HS1 myosin-null
1 ml of nearly confluent
The GFP sequence was integrated into the
Glass slides were coated with 10 μg/ml polylysine overnight. Approximately 1 ml of semi-confluent GMO8B
Live cells were transferred to imaging chambers (Applied Scientific, Santa Ana, California, United States) in HL-5 medium. GFP and FluoSphere fluorescence were imaged at room temperature using a Zeiss (Oberkochen, Germany) Axiovert 200 inverted epifluorescence microscope equipped with a 63× objective (N.A. 1.3). Cells were imaged at 20-s intervals. Images were collected using Metamorph (Universal Imaging Corporation, Downington, Pennsylvania, United States) and analyzed with ImageJ (NIH) and Photoshop (Adobe Systems, San Jose, California, United States).
We would like to thank Ben Spink for helping us analyze charge distributions with Microsoft Excel, John Perrino and Nafisa Ghori for assistance with negative staining EM, the Harbury lab for help with CD, Gary Pielak for providing resources and support at UNC-CH, and the Spudich lab for critical reading of the manuscript. Special thanks to Hans Warrick for several thorough reads of the manuscript. This work was supported by NIH GM46551 (JAS) and American Heart Association 0435341Z (SER and PMM).
Academic Editor: Manfred Schliwa, Adolf-Butenandt-Institut
¤1 Current address: Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America
¤2 Current address: Department of Cell and Molecular Biology, Northwestern University, Chicago, Illinois, United States of America
Citation: Hostetter D, Rice S, Dean S, Altman D, McMahon PM, et al. (2004)
myosin II with three threonine heavy chain phosphorylation sites at positions 1,823
myosin-II with three threonine heavy chain phosphorylation sites at positions 1,823
amino acid(s)
the 34-kDa assembly domain (a.a. 1,531–1,824)
the 68-kDa tail fragment starting at the AD and extending to the end of the C terminus of myosin-II (a.a. 1,531–2,116)
bipolar thick filament
circular dichroism
C-terminal domain (a.a. 1,967–2,116)
negative staining electron microscopy
green fluorescent protein
regulatory light chain
mean residue ellipticity at 222 nm